Glabridin Market
CAGR of 6.84%
Market Size
global Glabridin market was valued at USD 37.74 million in 2024 and is projected to reach USD 59.43 million by 2031, growing at a CAGR of 6.84% during the forecast period (2025-2031).
Market Dynamics
⚬Drivers - Rising Demand in Cosmetics: Glabridin is highly valued for its skinlightening properties and UV protection, making it a key ingredient in premium skincareproducts.
⚬Restraints - High Cost of Production: The extraction and purification process of Glabridin is complex and expensive, limiting itsaffordability.
⚬Opportunities -Expansion in Emerging Markets: Growing disposable income and increasing awareness of skincare benefits in developing regions provide significant opportunities.
Regional Analysis
North America
⚬Leading consumers include the U.S. and Canada.
⚬High demand from premium cosmetic brands.
Europe
⚬Strong presence of skincare and pharmaceutical industries.
⚬Increasing focus on organic skincare drives demand.
Market Segmentation Analysis
By End User
⚬20% (HPLC)
⚬40% (HPLC)
⚬60% (HPLC)
⚬90% (HPLC)
⚬98% (HPLC)
By Application
⚬CosmeticIndustry:Glabridin’s primaryapplicationduetoits skin-brighteningandanti-aging properties.
⚬PharmaceuticalIndustry:Usedin anti-inflammatoryand antimicrobialtreatments.
Key Company
• Sabinsa
• Mafco
• Maruzen Pharmaceuticals
• Hyundai Bioland
• Shanghai OLI
• Lepro Herbals
• Gansu Fanzhi Pharmaceutical
ABOUT US
Established ourselves in the year 2015, Intel Market Reports is a popular market research company that provides an in-depth quantified market research report. The Purpose - To deliver effective and fruit-bearing market research reports. Our portfolio includes the list of 30+ companies belonging to the Fortune 500 list. We have achieved this milestone in less thanhalfadecade.
